TY - JOUR
T1 - Post-sequelae symptoms and comorbidities after COVID-19
AU - Duggal, Priya
AU - Penson, Tristan
AU - Manley, Hannah N.
AU - Vergara, Candelaria
AU - Munday, Rebecca M.
AU - Duchen, Dylan
AU - Linton, Elizabeth A.
AU - Zurn, Amber
AU - Keruly, Jeanne C.
AU - Mehta, Shruti H.
AU - Thomas, David L.
N1 - Funding Information:
This study was supported by the Johns Hopkins University COVID‐19 Research Response Program (to P. D. and S. H. M.); National Institute of Allergy and Infectious Disease/National Institutes of Health (3R01AI148049‐21A1S1 to P. D. and D. L. T.); BWF Maryland: Genetics, Epidemiology and Medicine Training grant (to D. D., R. M. M.); and National Institute on Aging/National Institutes of Health (T32AG000247 to E. A. L.).
Publisher Copyright:
© 2022 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.
PY - 2022/5
Y1 - 2022/5
N2 - The frequency, severity, and forms of symptoms months after coronavirus 2019 (COVID-19) are poorly understood, especially in community settings. To better understand and characterize symptoms months after community-based COVID-19, a retrospective cohort analysis was conducted. Three hundred and twenty-eight consecutive persons with a positive test for SARS-CoV-2 in the Johns Hopkins Health System, Maryland, March−May 2020, were selected for the study. Symptom occurrence and severity were measured through questionnaires. Of 328 persons evaluated, a median of 242 days (109−478 days) from the initial positive SARS-CoV-2 test, 33.2% reported not being fully recovered and 4.9% reported symptoms that constrained daily activities. Compared to those who reported being fully recovered, those with post-acute sequelae were more likely to report a prior history of heart attack (p < 0.01). Among those reporting long-term symptoms, men and women were equally represented (men = 34.8%, women = 34.6%), but only women reported symptoms that constrained daily activities, and 56% of them were caregivers. The types of new or persistent symptoms varied, and for many, included a deviation from prior COVID-19 health, such as being less able to exercise, walk, concentrate, or breathe. A limitation is that self-report of symptoms might be biased and/or caused by factors other than COVID-19. Overall, even in a community setting, symptoms may persist months after COVID-19 reducing daily activities including caring for dependents.
AB - The frequency, severity, and forms of symptoms months after coronavirus 2019 (COVID-19) are poorly understood, especially in community settings. To better understand and characterize symptoms months after community-based COVID-19, a retrospective cohort analysis was conducted. Three hundred and twenty-eight consecutive persons with a positive test for SARS-CoV-2 in the Johns Hopkins Health System, Maryland, March−May 2020, were selected for the study. Symptom occurrence and severity were measured through questionnaires. Of 328 persons evaluated, a median of 242 days (109−478 days) from the initial positive SARS-CoV-2 test, 33.2% reported not being fully recovered and 4.9% reported symptoms that constrained daily activities. Compared to those who reported being fully recovered, those with post-acute sequelae were more likely to report a prior history of heart attack (p < 0.01). Among those reporting long-term symptoms, men and women were equally represented (men = 34.8%, women = 34.6%), but only women reported symptoms that constrained daily activities, and 56% of them were caregivers. The types of new or persistent symptoms varied, and for many, included a deviation from prior COVID-19 health, such as being less able to exercise, walk, concentrate, or breathe. A limitation is that self-report of symptoms might be biased and/or caused by factors other than COVID-19. Overall, even in a community setting, symptoms may persist months after COVID-19 reducing daily activities including caring for dependents.
KW - SARS-CoV-2
KW - long-haul
KW - post-COVID-19
KW - sequela
UR - http://www.scopus.com/inward/record.url?scp=85123909704&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123909704&partnerID=8YFLogxK
U2 - 10.1002/jmv.27586
DO - 10.1002/jmv.27586
M3 - Article
C2 - 35032030
AN - SCOPUS:85123909704
SN - 0146-6615
VL - 94
SP - 2060
EP - 2066
JO - Journal of Medical Virology
JF - Journal of Medical Virology
IS - 5
ER -